Antiviral Agents

Content: 
Copyright
Page iv

Preface
Pages ix-xii
Erik De Clercq

Contributors
Pages xiii-xiv

Chapter One - Antiviral Agents for Herpes Simplex Virus
Pages 1-38
R. Anthony Vere Hodge, Hugh J. Field

Chapter Two - Nucleotide Prodrugs for the Treatment of HCV Infection
Pages 39-73
Michael J. Sofia

Chapter Three - HIV Integrase Inhibitors: 20-Year Landmark and Challenges
Pages 75-105
Mathieu Métifiot, Christophe Marchand, Yves Pommier

Chapter Four - Advances in the Treatment of Varicella-Zoster Virus Infections
Pages 107-168
G. Andrei, R. Snoeck

Chapter Five - Hepatitis C Virus: Standard-of-Care Treatment
Pages 169-215
Jean-Michel Pawlotsky

Chapter Six - Influenza Virus Resistance to Antiviral Therapy
Pages 217-246
Erhard van der Vries, Martin Schutten, Pieter Fraaij, Charles Boucher, Albert Osterhaus

Chapter Seven - The Natural Course of Chronic Hepatitis B Virus Infection and Its Management
Pages 247-291
Stephanos J. Hadziyannis, Dimitrios Vassilopoulos, Emilia Hadziyannis

Chapter Eight - The Holý Trinity: The Acyclic Nucleoside Phosphonates
Pages 293-316
Erik De Clercq

Chapter Nine - The Nucleoside Reverse Transcriptase Inhibitors, Nonnucleoside Reverse Transcriptase Inhibitors, and Protease Inhibitors in the Treatment of HIV Infections (AIDS)
Pages 317-358
Erik De Clercq

Index
Pages 359-369